Neumora Therapeutics Inc

Insider confidence shines as Kristina Burow and other execs buy 80,000 options in Neumora Therapeutics, hinting at upside amid market volatility and a low 52‑week price.

Neumora Therapeutics sees a big insider option surge—board buys 4.65M shares, hinting at confidence in future milestones and potential upside.

Neumora’s insiders buy 4.5 M shares of stock‑options, signaling confidence in its brain‑therapy pipeline and a bullish outlook for the neuro‑pharma sector.